about
Mouse models for radiation-induced cancersMouse models for efficacy testing of agents against radiation carcinogenesis—a literature reviewCancer survivors' uptake and adherence in diet and exercise intervention trials: an integrative data analysis.Comparison of second cancer risks from brachytherapy and external beam therapy after uterine corpus cancer.Testicular cancer survivorship: research strategies and recommendations.Induction of the Cdk inhibitor p21 by LY83583 inhibits tumor cell proliferation in a p53-independent manner.Riding the crest of the teachable moment: promoting long-term health after the diagnosis of cancer.Biological response to radiation therapy.Breast cancer survivorship: a comprehensive review of long-term medical issues and lifestyle recommendations.Second cancers in patients with chronic lymphocytic leukemia who received frontline fludarabine, cyclophosphamide and rituximab therapy: distribution and clinical outcomes.Cost-effectiveness of proton radiation in the treatment of childhood medulloblastoma.Genetic susceptibility to iatrogenic malignancy.The potential of proton beam therapy in paediatric cancer.The potential of proton beam radiation therapy in breast cancer.The potentials of proton beam radiation therapy in malignant lymphoma, thymoma and sarcoma.Risk of second cancers after radiotherapy for cervical cancer.Cancer survivorship--genetic susceptibility and second primary cancers: research strategies and recommendations.Family history of breast cancer and young age at diagnosis of breast cancer increase risk of second primary malignancies in women: a population-based cohort studyCancer survivorship research: state of knowledge, challenges and opportunities.Long-term Toxicity of Cancer Treatment in Older PatientsManagement of optic-hypothalamic gliomas in children: still a challenging problem.Incident malignancies among older long-term breast cancer survivors and an age-matched and site-matched nonbreast cancer comparison group over 10 years of follow-up.Solid tumors after chemotherapy or surgery for testicular nonseminoma: a population-based study.Secondary malignant neoplasms after childhood cancer.Aetiology, genetics and prevention of secondary neoplasms in adult cancer survivors.Secondary Cancers After Radiation Therapy for Primary Prostate or Rectal Cancer.Pattern of occurrence and treatment outcome of second primary malignancies: A single center experience.Liposomal anthracycline chemotherapy and the risk of second malignancies in patients with Kaposi's sarcoma (KS).Prevalence of multiple malignancies in the Netherlands in 2007.Synchronous and metachronous malignancies: analysis of the Minneapolis Veterans Affairs (VA) tumor registry.Risk of second primary cancers in cancer patients treated with cisplatin: a systematic review and meta-analysis of randomized studies.Hemangiosarcoma and squamous cell carcinoma in the third eyelid of a horse.Long-term sequelae after cancer therapy--a necessary consequence of success?Toxicities Associated with Cisplatin-Based Chemotherapy and Radiotherapy in Long-Term Testicular Cancer Survivors.Post-radiation sarcomas. Clinical outcome of 52 PatientsSecond Cancers Among 104760 Survivors of Cervical Cancer: Evaluation of Long-Term RiskSecond Cancers Among 40 576 Testicular Cancer Patients: Focus on Long-term Survivors
P2860
Q26747129-26E6CBDE-8C0A-4FCE-ABA3-AF77BEBBF1C7Q26999068-13615C48-7DEB-4FD4-8860-7EBB58001D51Q30844813-DC096B53-BAC0-4FB4-9C76-08BFE9CA0E2FQ33838842-BA08DDDE-50C8-4129-A970-BBF48B9B4A3AQ34039684-CF2984DE-4B34-4B10-B0E9-9ED0D627444FQ34817143-6D5BE70E-D71C-466D-8414-589DCC582FE7Q34997308-A67B3DAB-4422-4DA8-B9AF-3EDB8D1282EAQ35151872-375804A0-5660-4813-858E-65AB40D52FEAQ35490056-16EA9EA7-3E06-4247-9E1D-F40A78717973Q35625192-F82A66DC-8217-4671-9BA4-654B869CD378Q36002345-7347418C-7026-4764-A1E2-47F4CE258C9FQ36249238-5988D548-D5A6-403E-8D8B-992CF6C63314Q36333003-B655AE9D-F92C-437F-97D5-8AA7AB85DA82Q36333013-8B2F7666-5E21-4DD5-8169-BD0145EE67DFQ36333025-2496C77F-7E0E-4889-BD64-AE2968448457Q36352077-92DAA563-06D0-461A-83BC-60464E376FA9Q36359653-14003947-983B-44D6-811B-5EDB469C0D89Q36611869-DF003A16-9C67-40FF-8074-C1A92EB7CBDCQ36819541-3C21A251-B0CF-4F8E-8C99-6E5CDAF61B58Q36821673-170FA4BA-3771-48B3-A368-350ACD462BBFQ37004680-A39E5188-7D50-41B7-8B79-62CAF1AED230Q37085571-51D6652C-DF30-45EC-9444-DE407C4C3D0BQ37227682-9EC08148-0058-407F-9190-DF4335B48B17Q37854051-4EFEE344-BF7E-41AA-B3D7-2A7E3D376C6CQ38093037-44312F7F-4227-425A-83ED-EDF0BCF55C53Q38681708-00A1C0A8-D764-4598-9E6D-FD3E096277D6Q41849244-6997CD0F-82D2-4A1C-AF1F-BBCB5D9026C5Q42204251-4BDB689A-46C4-4D8B-AEF7-A717FE0DBE81Q44127734-C2CF941B-C762-4138-BB5C-8E45FDE393E4Q45329472-D9FDEADC-080F-4EBA-96FF-2BEFD41799A3Q47100585-2AB05CDB-8C1F-465F-B8AD-09C58D556C6CQ50703900-065F3DDE-358D-4319-9BD5-1E7ECC3BF0AAQ54401193-7BD61AC0-31DE-4119-9EFC-488BDFCCCDF1Q55162138-F8BBDD3A-F688-4DF6-9A35-FDCE773B1451Q56981795-0A13B6BC-8631-4E64-A547-63D5F39ADB50Q58410884-1256CEE3-8F94-4FEF-8489-D59C7C9F34FDQ58411051-42C43046-1980-4367-99AF-B1EC43F8A1F1
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Therapy-associated solid tumors.
@ast
Therapy-associated solid tumors.
@en
Therapy-associated solid tumors.
@nl
type
label
Therapy-associated solid tumors.
@ast
Therapy-associated solid tumors.
@en
Therapy-associated solid tumors.
@nl
prefLabel
Therapy-associated solid tumors.
@ast
Therapy-associated solid tumors.
@en
Therapy-associated solid tumors.
@nl
P1433
P1476
Therapy-associated solid tumors.
@en
P2093
Lois B Travis
P304
P356
10.1080/028418602760169361
P577
2002-01-01T00:00:00Z